Current diagnosis and treatment of visceral leishmaniasis.
about
Developments in Diagnosis of Visceral Leishmaniasis in the Elimination EraRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisRisk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysisIron overload favors the elimination of Leishmania infantum from mouse tissues through interaction with reactive oxygen and nitrogen speciesHemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infectionAlkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activityTrypanosomatid RACK1 orthologs show functional differences associated with translation despite similar roles in Leishmania pathogenesisParasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.Diagnosis and identification of Leishmania spp. from Giemsa-stained slides, by real-time PCR and melting curve analysis in south-west of IranNaturally occurring culturable aerobic gut flora of adult Phlebotomus papatasi, vector of Leishmania major in the Old World.Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosineTherapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOMEā¢10, a new liposomal amphotericin B.A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B.Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana.Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial ActivityN-cinnamoylated aminoquinolines as promising antileishmanial agents.Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.Therapy of vector-borne protozoan infections in nonendemic settings.Leishmania antimony resistance: what we know what we can learn from the field.Diagnosis of visceral leishmaniasis: developments over the last decade.Challenges in the therapy of visceral leishmaniasis in Brazil: a public health perspective.Immunity to visceral leishmaniasis: implications for immunotherapy.Rapid identification of Leishmania spp. in formalin-fixed, paraffin-embedded tissue samples by fluorescence in situ hybridization.Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.Application of Ultrasonography in the Diagnosis of Infectious Diseases in Resource-Limited Settings.Evaluating drug resistance in visceral leishmaniasis: the challenges.Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis.Case report: Acute renal injury as a result of liposomal amphotericin B treatment in sodium stibogluconate unresponsive visceral leishmaniasisInterest in paromomycin for the treatment of visceral leishmaniasis (kala-azar).Profile and geographic distribution of reported cases of visceral leishmaniasis in Campo Grande, State of Mato Grosso do Sul, Brazil, from 2002 to 2009.Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient.Genomic analysis of Isometamidium Chloride resistance in Trypanosoma congolense.Potential application of rLc36 protein for diagnosis of canine visceral leishmaniasis.Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis.
P2860
Q26769062-3A42B317-3FD7-449D-909A-BD9905B5D89BQ27011766-FA7E56F6-922C-44C8-BAC0-896123CE2820Q27024638-B1BCB111-7865-45C5-94AA-020B77DD4084Q27305261-9D537B6F-80A7-4FF1-A54C-F728AF7CFF38Q28492881-554942C9-04E7-473E-83D3-99568FBC5358Q33622864-09DA24C1-D31B-41E7-9F39-A8B81522019BQ33934065-4D079429-3C88-48E3-B86D-3936AEDBBC8AQ33955428-24F4B9B3-77F7-4B19-8114-2F7BF1AAE2B0Q34156446-E407A6C0-41B9-42CA-A85D-F313C9B854A2Q34281532-C78899DE-F2E5-4647-90D5-023453841CA0Q34328882-04EAE515-CFA0-4BDE-AC5F-A523B0D6E8BEQ34662190-90B9739A-087A-49A9-BE1F-89FC46849D17Q34707796-7082F6EB-2C71-4A5D-B5B0-66DF41EEBC45Q35605511-C9B446DF-C5E7-4B6E-998A-3E2512FBE142Q35687444-DB77C722-9E6E-4F2A-845F-DEC5B1854D14Q36086604-1E28E748-37D6-4122-8BF2-60AF959231E8Q36163680-4BCE3227-0FA4-4A35-A389-F46822197896Q36272948-A3433501-AD2C-47EC-B175-968C1B324C67Q36523002-C9911B73-95D9-4A8F-9504-F9F258970493Q37249872-EAF22AAD-88EA-4B34-9D56-E682C1D6D2CEQ37263882-AF7FFCC0-7E18-4FBE-B45C-71CA835D34EEQ37639367-F48DF6BC-549A-48BE-8417-23E2A6CCABA7Q37879203-7D24B99B-973C-4BD9-90E9-F24FF4B61841Q37907925-E4A7D7C3-0A3B-4154-916B-E95202724873Q37953841-F529B49E-6F8D-497E-8091-C662E99FC5C6Q38175140-E31A32BC-3FA3-4869-B34D-1F5C4E1ED383Q38243220-AD2B314E-608D-41A7-8847-89CA77A9F69DQ38323721-63F9519E-FD2B-4085-87D5-BE0AD0C704C8Q38364470-6B927FA7-81DC-4A3C-B1AA-B0294E193200Q38924047-20BA8228-5231-46FE-BB28-8DB72523F86EQ39014583-D39AEAA6-F04F-4CA1-92E4-B6F122DB193BQ39156593-B39EEAF4-11ED-4B0D-891F-EF58BFE33BE2Q39409919-FEA458A3-8219-4876-B450-6796B6576CB0Q39599468-1037D577-8465-4CCA-AE4D-6252E636B4FBQ40074767-88A73845-D512-498C-83CA-0594AC328264Q41656767-FF3A8336-BA57-4ECF-8B97-F0730E3ACC9CQ42159070-484F2FCF-2363-45E5-8EE4-56FB7AC3465FQ42379576-32415B98-F12C-4ECD-9A88-3340C5ABD2E6Q50142182-1FEE4F58-1EEC-44F9-AB95-2DC763BF6215Q53088160-C1CD7A04-ACE1-4695-A0B5-3D1E7D9503E5
P2860
Current diagnosis and treatment of visceral leishmaniasis.
description
article cientĆfic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo cientĆfico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedeckĆ½ ÄlĆ”nok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vÄdeckĆ½ ÄlĆ”nek
@cs
name
Current diagnosis and treatment of visceral leishmaniasis.
@en
Current diagnosis and treatment of visceral leishmaniasis.
@nl
type
label
Current diagnosis and treatment of visceral leishmaniasis.
@en
Current diagnosis and treatment of visceral leishmaniasis.
@nl
prefLabel
Current diagnosis and treatment of visceral leishmaniasis.
@en
Current diagnosis and treatment of visceral leishmaniasis.
@nl
P2093
P2860
P356
P1476
Current diagnosis and treatment of visceral leishmaniasis.
@en
P2093
Pradyot Bhattacharya
Smriti Mondal
P2860
P304
P356
10.1586/ERI.10.78
P577
2010-08-01T00:00:00Z